Recombinant single-chain Fv antibodies that recognize the p25 protein of the maedi-visna virus

Folia Microbiologica

Volumn 48, Issue 3, 2003, Pages 435-440

  Celer, V ^a   Blazek D ^a   Navratilova I ^b   Skladal P ^b   Blacklaws, B ^c   Bujdoso, R ^c  

^a UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MAEDI-VISNA VIRUS; VISNA VIRUS;

EID: 0042887669     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931380     Document Type: Article

References (21)

1. ADAMS G.P., SCHIER R.: Generating improved single-chain Fv molecules for tumor targeting. J.Immunol.Meth. 231, 249-260 (1999).
2. CARDOSO D.F., NATO F., ENGLAND P., FERREIRA M.L., VAUGHAN T.J., MOTA I., MAZIE J.C., CHOUMET V., LAFAYE P.: Neutralizing human anti-crotoxin scFv isolated from a nonimmunized phage library. Scand.J.Immunol. 51, 337-344 (2000).
3. CELER V. JR., CELER V.: Detection of antibodies to ovine lentivirus using recombinant capsid and transmembrane proteins. J.Vet.Med. 48, 89-95 (2001).
4. COCHET O., GRUEL N., FRIDMAN W.H., TEILLAUD J.L.: Ras and p53 intracellular targeting with recombinant single-chain Fv (scFv) fragments: a novel approach for cancer therapy? Cancer Detect.Prev. 23, 506-510 (1999).
5. FEVEREIRO M., BARROS S., FAGULHA T.: Development of a monoclonal antibody blocking-ELISA for detection of antibodies against Maedi-Visna vires. J.Virol.Meth. 81, 101-108 (1999).
6. GELMETTI D., GIBELLI L., BROCCHI E., CAMMARATA G.: Using a panel of monoclonal antibodies to detect Maedi virus (MV) in chronic pulmonary distress of sheep. J.Virol.Meth. 88, 9-14 (2000).
7. GENDELMAN H.E., NARAYAN O., KENNEDY-STOSKOPF S.: Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J.Virol. 58, 67-74 (1986).
8. GRIFFITHS A.D., WILLIAMS S.C., HARTLEY O., TOMLINSON I.M., WATERHOUSE P., CROSBY W.L., KONTERMANN R.E., JONES P.T., LOW N.M., ALLISON T.J.: Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. 13, 3245-3260 (1994).
9. GUDNADOTTIR M.: Visna-Maedi in sheep. Progr.Med.Virol. 18336-18349 (1974).
10. DE HAARD H. J., KAZEMIER B., KOOLEN M.J., NIJHOLT L.J., MELOEN R.H., VAN GEMEN B., HOOGENBOOM H.R., ARENDS J.W.: Selection of recombinant, library-derived antibody fragments against p24 for human immunodeficiency virus type 1 diagnostics. Clin.Diagn.Lab.Immunol. 5, 636-644 (1998).
11. LI Y., COCKBURN W., KILPATRICK J.B., WHITELAM G.C.: High affinity ScFvs from a single rabbit immunized with multiple haptens. Biochem.Biophys.Res.Commun. 268, 398-404 (2000).
12. LOU J., MARZARI R., VERZILLO V., FERRERO F., PAK D., SHENG M., YANG C., SBLATTERO D., BRADBURY A.: Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries. J.Immunol.Meth. 253, 233-242 (2001).
13. MALMBORG A.C., BORREBAECK C.A.K.: BIAcore as a tool in antibody engineering. J.Immunol.Meth. 183, 7-13 (1995).
14. MARASCO W.A., LA VECCHIO J., WINKLER A.: Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS. J.Immunol.Meth. 231, 223-238 (1999).
15. MARKS J.D., HOOGENBOOM H.R., BONNERT T.P., MCCAFFERTY J., GRIFFITHS A.D., WINTER G.: By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J.Mol.Biol. 222, 581-597 (1991).
16. MHASHILKAR A.M., BISWAS D.K., LA VECCHIO J., PARDEE A.B., MARASCO W.A.: Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-κB antagonists. J. Virol. 71, 6486-6494 (1997).
17. MULLER B.H., LAFAY F., DEMANGEL C., PERRIN P., TORDO N., FLAMAND A., LAFAYE P., GUESDON J.L.: Phage-displayed and soluble mouse scFv fragments neutralize rabies virus. J.Virol.Meth. 67, 221-233 (1997).
18. POWER B.E., HUDSON P.J.: Synthesis of high avidity antibody fragments (scFv multimers) for cancer imaging. J.Immunol.Meth. 242, 193-204 (2000).
19. SCHUCK P.: Kinetics of ligand binding to receptor immobilized in a polymer matrix, as detected with an evanescent wave biosensor. A computer simulation of the influence of mass transport. Biophys.J. 70, 1230-1249 (1996).
20. SHEETS M.D., AMERSDORFER P., FINNERN R., SARGENT P., LINDQUIST E., SCHIER R., HEMINGSEN G., WONG C., GERHART J.C., MARKS J.D., LINDQVIST E.: Efficient construction of a large non-immune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. Proc.Nat.Acad.Sci.USA 95, 6157-6162 (1998).
21. SONIGO P., ALIZON M., STASKUS K., KLATZMANN D., COLE S., DANOS O., RETZEL E., TIOLLAIS P., HAASE A., WAIN-HOBSON S.: Nucleotide sequence of the Visna lentivirus: relationship to the AIDS virus. Cell 42, 369-382 (1985).